Advertisement
Home 2020 April

Monthly Archives: April 2020

March 2020 Briefing – Allergy

Here are what the editors at HealthDay consider to be the most important developments in Allergy for March 2020. This roundup includes the latest...
About one-third of patients with coronavirus disease 2019 have ocular abnormalities

Ocular Abnormalities Seen in One-Third of COVID-19 Patients

Patients with ocular symptoms more likely to have higher white blood cell count, neutrophil count
Liraglutide plus lifestyle therapy results in a significantly greater reduction in body mass index standard-deviation score than placebo among adolescents with obesity

ENDO: Liraglutide May Benefit Adolescents With Obesity

Reduction in BMI standard-deviation score greater for liraglutide + lifestyle therapy versus placebo
Patients with mild coronavirus disease 2019 can present with digestive symptoms

Patients With Mild COVID-19 May Present With Digestive Symptoms

Many with digestive symptoms present with diarrhea; 62.4 percent with digestive symptoms have fever
The burden of childhood cancer can be effectively diminished to realize health and economic benefits

Burden of Childhood Cancer Can Be Diminished

Comprehensive scale-up of interventions could avert 6.2 million deaths in children with cancer
There are four developmental patterns of peer victimization across childhood

Four Trajectories of Peer Victimization ID’d Across Childhood

Paternal history of antisocial behavior tied to moderate-emerging, high-chronic versus low peer victimization
Older patients taking five or more medications in the six months before intravenous chemotherapy are at higher risk for postchemotherapy inpatient hospitalizations

Polypharmacy Ups Postchemo Hospitalization Risk in Seniors

Findings seen in older patients with prostate, breast, and lung cancers
Vitamin D deficiencies are associated with a lower likelihood of older patients regaining independent walking ability following hip fracture surgery

Low Vitamin D May Reduce Mobility After Hip Fracture Surgery

Rates of walking at 30 days higher for those with 25(OH)D levels ≥12 ng/mL versus <12 ng/mL
For patients with type 2 diabetes

ENDO: Glycemic Control Good for Regular Human Insulin With V-Go

Mean change in HbA1c not significantly different with regular human insulin, rapid-acting insulin